BSE See NSE See 49,580.73
848.18 (1.74%)


Shruti Jadhav / Article rating: 3.5

Dalal Street Investment Journal has always been a pioneer in adopting the best practices so that our readers not only read the journal, but act in a prudent manner to take some sound decisions. Keeping in mind our logo “Democratising wealth creation,” we are pleased to have ranked 100 best business schools of the country, keeping the authenticity and objective of our tagline, intact. 


Vishal Dolas / Article rating: No rating

While some of the institutes are really striving to become world class in all respects, there are a good number of institutes that are running on expired courses and inefficient methods. In this era of intense competition and numerous choices, it is essential to be informed and aware of the relevant institutes and courses on offer.

DSIJ Mindshare

Alembic Pharmaceuticals plunge despite getting USFDA nod for Lurasidone Hydrochloride tablets

Shruti Dahiwal / Article rating: 3.7

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).  

Zydus Cadila to sell animal health business to an asset management-led consortium

Shruti Dahiwal / Article rating: 4.4

Cadila Healthcare Ltd, a global pharmaceutical company, announced today that its wholly-owned subsidiary, Zydus Animal Health & Investments Limited (ZAHL) has entered into a business transfer agreement (BTA) to sell & transfer its animal healthcare established markets undertaking (Zydus AH) to a consortium, which is led by Multiples Alternate Asset Management.